Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Taina, Heikkilä"'
Autor:
Sherif Bayoumy, Iida Martiskainen, Taina Heikkilä, Carita Rautanen, Pirjo Hedberg, Heidi Hyytiä, Saara Wittfooth, Kim Pettersson
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Measurement of cardiac troponin I (cTnI) should be feasible for point-of-care testing (POCT) to diagnose acute myocardial infarction (AMI). Lateral flow immunoassays (LFIAs) have been long implemented in POCT and clinical settings. However,
Externí odkaz:
https://doaj.org/article/1c5b42e46de54f6fbac46bc0d21ec2a3
Autor:
Priyanka Negi, Taina Heikkilä, Karoliina Vuorenpää, Emilia Tuunainen, Wail Nammas, Teemu Maaniitty, Juhani Knuuti, Jari Metso, Janita Lövgren, Matti Jauhiainen, Urpo Lamminmäki, Kim Pettersson, Antti Saraste
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveHigh-density lipoprotein (HDL) is a heterogeneous group of subpopulations differing in protein/lipid composition and in their anti-atherogenic function. There is a lack of assays that can target the functionality of HDL particles related to
Externí odkaz:
https://doaj.org/article/d8f5248c1ad345a0a3d4f9e782875e22
Autor:
Priyanka, Negi, Taina, Heikkilä, Terhi, Tallgren, Päivi, Malmi, Juha, Lund, Juha, Sinisalo, Jari, Metso, Matti, Jauhiainen, Kim, Pettersson, Urpo, Lamminmäki, Janita, Lövgren
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 194
High density lipoproteins (HDL) are a heterogenous group of subpopulations differing in protein/lipid composition and in their anti-atherogenic function. There is a lack of specific and robust assays which can target the functionality of HDL with res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d0bfe4db0c512d2226d872a93be5f8a
https://pubmed.ncbi.nlm.nih.gov/33309125
https://pubmed.ncbi.nlm.nih.gov/33309125
Autor:
Taina Heikkilä, R. Lankinen, Urpo Lamminmäki, Matti Jauhiainen, Priyanka Negi, K. Vuorenpää, Kim Pettersson, J. Lovgren
Publikováno v:
Clinica Chimica Acta. 493:S10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56630000da71ef02f47a7a68e8c962e0
https://doi.org/10.1016/j.cca.2019.04.026
https://doi.org/10.1016/j.cca.2019.04.026
Autor:
Eeva-Christine Brockmann, Timo Lövgren, Pirjo Hedberg, Heidi Hyytiä, Tarja Puolakanaho, Henna Kekki, Taina Heikkilä, Kim Pettersson
Publikováno v:
Clinical Biochemistry. 48(4-5)
Objectives To introduce a novel nanoparticle-based immunoassay for cardiac troponin I (cTnI) utilizing chimeric antibody fragments and to demonstrate that removal of antibody Fc-part and antibody chimerization decrease matrix related interferences. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f70f6b14ea7d14f0b2c356b0e4ffe83
http://juuli.fi/Record/0006595115
http://juuli.fi/Record/0006595115
Autor:
Kim Pettersson, Terhi Tallgren, Urpo Lamminmäki, Priyanka Negi, Taina Heikkilä, Matti Jauhiainen, Janita Lövgren
Publikováno v:
Atherosclerosis. 252:e104-e105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd57985c3ec0cdcba2737bf70673e6d
https://doi.org/10.1016/j.atherosclerosis.2016.07.585
https://doi.org/10.1016/j.atherosclerosis.2016.07.585
Publikováno v:
Clinical biochemistry. 48(4-5)
Objectives To study the skeletal troponin I (skTnI) cross-reactivity of four different commercially available antibodies in four cardiac troponin I (cTnI) research assay versions having the same epitope specificity as evidenced by peptide mapping. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8605cce473e281c8e84251f7c31d0b94
https://pubmed.ncbi.nlm.nih.gov/25583092
https://pubmed.ncbi.nlm.nih.gov/25583092